| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10298606 | European Neuropsychopharmacology | 2016 | 12 Pages |
Abstract
Overall, these results shed new light on the neurobiological mechanisms used by antipsychotic drugs to reverse NMDA-R antagonist actions and suggest that agents restoring the physiological excitatory/inhibitory balance altered by PCP may be new targets in antipsychotic drug development.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
L. Lladó-Pelfort, E. Troyano-Rodriguez, H.E. van den Munkhof, A. Cervera-Ferri, N. Jurado, M. Núñez-Calvet, F. Artigas, P. Celada,